September 26, 2011
J.K. WallIf approved for continuation maintenance, Eli Lilly and Co.'s Alimta could be used for longer stretches in lung cancer patients,
generating more revenue.
More
September 19, 2011
J.K. WallExecutives at Roche Diagnostics expect the wave of austerity measures being taken by western governments—including the
United States—to as much as double its sales of fluid- and DNA-based tests in the next three years.
More
September 15, 2011
Associated PressA former Indiana scientist has agreed to plead guilty to charges of illegally sending trade secrets worth $300 million to
China and Germany.
More
August 24, 2011
J.K. WallMarian disclosed Evans’ 2010 donation Wednesday as it held a groundbreaking ceremony for its medical and nursing school
building, which will be called the Michael A. Evans Center for Health Sciences.
More
August 22, 2011
J.K. WallNew drug for metastatic melanoma packaged with genetic test should help Roche sell more of its cobas 4800 laboratory testing
systems.
More
August 13, 2011
Chris O'MalleyLicensed practical nurse Nic Davis invented a device to kill and prevent the introduction of microorganisms that collect at
catheter ports.
More
August 13, 2011
IBJ StaffA $10 million research endowment at the Eugene and Marilyn Glick Eye Institute has attracted seven new researchers to the
Indiana University School of Medicine’s Ophthalmology Department.
More
August 8, 2011
J.K. WallFour Hoosier companies attracted more than $10.5 million, down from 10 companies that attracted $18.5 million during the first
half of 2010.
More
August 8, 2011
Bloomberg NewsThe Warsaw-based company has sued seven law firms this year and sent warning letters to at least three more, saying their
ads and Internet postings distorted the safety record of its $1.8 billion-a-year knee business.
More
August 4, 2011
Associated PressRochester Medical Implants plans to move operations from Rochester to Noblesville in October. The company has 28 employees.
More
August 2, 2011
Indianapolis-based DGP Intelsius LLC, a manufacturer and distributor of temperature-controlled packaging, announced on Tuesday
morning that it plans to add 80 jobs by 2014 as part of an $870,000 expansion.
More
July 30, 2011
Maria LaMagnaThe U.S. Food and Drug Administration's growing reputation for unpredictability is spurring some Indianapolis companies to
join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations
occurring in their backyards.
More
July 30, 2011
Chris O'MalleyFormer Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez
and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry
in Indiana to venture capital and Purdue's Discovery Park.
More
July 30, 2011
Greg AndrewsAn investment firm projects that the Elanco animal-health business will generate sales of nearly $2 billion by 2012 and surpass
$3 billion by 2018.
More
July 27, 2011
Chris O'Malley
StepStone Business Partners has added a chapter in biotech hotbed Warsaw as part of what it hopes will eventually
become a statewide network.
More
July 27, 2011
Second-quarter revenue for the Indianapolis-based company increased 18 percent, to $1.5 billion. The company attributed the
gain to higher prices and stronger demand for its products.
More
July 23, 2011
Scott OlsonThe Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
More
July 21, 2011
Bloomberg NewsPfizer Inc., the world’s biggest drugmaker, said it isn’t interested in breaking up its animal health unit after
Indianapolis-based Eli Lilly and Co. expressed interest in buying some of its products.
More
July 5, 2011
Bloomberg NewsThe High Court in London on Tuesday denied Lilly’s request for a judgment without trial against Neopharma Ltd., the
closely held company that has European marketing rights for the generic version of the drug known chemically as olanzapine.
More
July 5, 2011
J.K. WallEli Lilly and Co.’s foray into combination drugs is well-timed because the company could take advantage of some the
world’s most successful biotech medicines, which are about to see their patents expire.
More
June 28, 2011
J.K. WallIndianapolis-based drugmaker Eli Lilly on Tuesday will announce a multimillion-dollar investment to develop drugs that act
like two medicines in one. Lilly plans to add more scientists to back the effort.
More
June 23, 2011
Bloomberg NewsThe U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly
& Co. CEO John Lechleiter plans to tell a technology conference Thursday.
More
June 18, 2011
Norm HeikensDespite enjoying rising revenues and profits, companies haven't followed with big increases in job numbers.
More
June 16, 2011
Francesca JaroszOfficials on Thursday shared details of a long-term plan to redevelop an industrial stretch northwest of downtown with the
goal of attracting hundreds of residents and dozens of high-tech companies to the area.
More
June 13, 2011
J.K. WallVi Shukla is a scientific leader at Indianapolis-based Dow AgroSciences LLC, focused on its Exzact Precision
Technology tools for genetic engineering of plants and crops. Dow Agro used the technology in its own crop seed products,
and has also been licensing for use in tomatos and trees.
More
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!